This document summarizes several aminoacidopathies, which are metabolic disorders caused by defects in the metabolism of amino acids. It lists the metabolic defect, consequences, manifestations, and treatment for several conditions including phenylketonuria (PKU), tyrosinemia types I-III, alkaptonuria, maple syrup urine disease (MSUD), isovaleric acidemia, and homocystinuria. PKU results from a lack of the enzyme PAH and causes high phenylalanine levels if untreated, leading to intellectual disability. Treatment involves a low-phenylalanine diet. Tyrosinemia type I is caused by a lack of fumarylacetoacetate hydrolase and manifests as liver
This document summarizes several aminoacidopathies, which are metabolic disorders caused by defects in the metabolism of amino acids. It lists the metabolic defect, consequences, manifestations, and treatment for several conditions including phenylketonuria (PKU), tyrosinemia types I-III, alkaptonuria, maple syrup urine disease (MSUD), isovaleric acidemia, and homocystinuria. PKU results from a lack of the enzyme PAH and causes high phenylalanine levels if untreated, leading to intellectual disability. Treatment involves a low-phenylalanine diet. Tyrosinemia type I is caused by a lack of fumarylacetoacetate hydrolase and manifests as liver
This document summarizes several aminoacidopathies, which are metabolic disorders caused by defects in the metabolism of amino acids. It lists the metabolic defect, consequences, manifestations, and treatment for several conditions including phenylketonuria (PKU), tyrosinemia types I-III, alkaptonuria, maple syrup urine disease (MSUD), isovaleric acidemia, and homocystinuria. PKU results from a lack of the enzyme PAH and causes high phenylalanine levels if untreated, leading to intellectual disability. Treatment involves a low-phenylalanine diet. Tyrosinemia type I is caused by a lack of fumarylacetoacetate hydrolase and manifests as liver
This document summarizes several aminoacidopathies, which are metabolic disorders caused by defects in the metabolism of amino acids. It lists the metabolic defect, consequences, manifestations, and treatment for several conditions including phenylketonuria (PKU), tyrosinemia types I-III, alkaptonuria, maple syrup urine disease (MSUD), isovaleric acidemia, and homocystinuria. PKU results from a lack of the enzyme PAH and causes high phenylalanine levels if untreated, leading to intellectual disability. Treatment involves a low-phenylalanine diet. Tyrosinemia type I is caused by a lack of fumarylacetoacetate hydrolase and manifests as liver
Phenylketonuria Inherited as an ART Absence of enzyme PAH — PHE levels: > 1200 mmol/L — Brain problems — Fetal effects of maternal PKU — Upper limit for PHE level in — Musty odor of urine is prevented if the mother is newborns: 120 mmol/L (2 mg/dL) — Retarded mental development maintained on PHE-restricted — Untreated PKU: > 2.4 mM/L and microcephaly in infants diet Enzyme Deficiency Deficiency in the enzymes — Elevated levels of PHE — Goal of the treatment: needed for the regeneration — Deficient production of maintain PHE blood levels and synthesis of neurotransmitters from TYR and between 2-10 mg/dL (120-600 tetrahydrobiopterin (BH4) TRP mol/L) — Avoid foods that are rich in protein Tyrosinemia Type I Low levels of enzyme — Tyrosine and tyrosine catabolites — Failure to thrive — Low-protein diet fumarylacetoacetate in urine — Diarrhea hydrolase — Vomiting — Jaundice — Cabbage-like odor — Distended abdomen — Swelling of legs — Increased predisposition for bleeding Type II Deficiency of enzyme tyrosine — Mental retardation (50%) aminotransferase — Excessive tearing — Photophobia — Eye pain and redness — Painful skin lesions on the palms and soles of the feet Type III Deficiency of the enzyme 4- — Mental retardation hydroxyphenylpyruvate — Seizures dioxygenase — Periodic loss of balance and coordination Alkaptonuria Inherited as an Lack of the enzyme — Defect in the metabolism of — Urine turns brownish-black — High-dose Vit C ARG, (HGD gene) homogentisate oxidase tyrosine and phenylalanine when mixed with air (due to HGA) — Ochronosis (pigments in tissues) — Arthritis-like degeneration — Dark spots on the sclera — Pigments in the cartilage of the ears, nose, and tendons, and extremities Maple Syrup Absence or reduced activity — Defect in the metabolism of LEU, — Maple syrup or burnt sugar — Protein-restrictive diet to Urine Disease of enzyme branched-chain- ILE, and VAL resulting in odor of the urine, breath, and lower the levels of (MSUD) ketoacid decarboxylase accumulation in blood, urine, and skin accumulating isovaleric acid, CSF — Infants: lethargy, vomiting, lack which is toxic to the CNS of appetite, and failure to thrive — CNS symptoms: muscle rigidity, stupor, and respiratory irregularities — Severe mental retardation, seizures, acidosis, and hypoglycemia — Death is left untreated Isovaleric Anemia Deficiency of the enzyme — Defect in the metabolism of the — Sweaty feet odor — Protein-restrictive diet to isovaleryl-CoA branched-chain amino acid LEU — In severe cases, it could cause lower the levels of dehydrogenase damage to the brain and accumulating isovaleric acid, nervous system which is toxic to the CNS — In infants: failure to thrive, vomiting, lethargy that can progress to seizures, coma, and death Homocystinuria Lack of the enzyme — Elevated plasma and urine levels — Infants: relatively healthy — Dietary restriction of cystathionine- synthetase of MET and of the precursor — Late childhood: osteoporosis, methionine (low protein) as homocysteine dislocated lenses in the eye, and well as high doses of vitamin mental retardation B6 — Multisystemic disorders of the CT, muscles, CNS, thinning and weakening of bones, and thrombosis if left untreated Citrullinemia Type I- GD Urea cycle disorder — — — High-calorie, protein- Type II- GD — — restrictive diet — Arginine supplementation — Administration of sodium benzoate and sodium phenylacetate Argininosuccinic Genetic Disease Lack of the enzyme — Elevated levels of argininosuccinic — In newborn: lethargy and — High-calorie, protein- Aciduria argininosuccinic acid lyase also cause buildup of the amino unwillingness to eat restrictive diet acid citrulline in the blood — Arginine supplementation — Urea cycle cannot proceed — Administration of sodium normally and nitrogen benzoate and sodium accumulates in the blood in the phenylacetate form of ammonia. Ammonia is neurotoxic & hepatotoxic. Cystinuria Defect in the amino acid — Inadequate reabsorption of — Hematuria, pain in the side due — Increasing the volume of urine transport system rather than cystine during the filtering to kidney pain, and UTI to reduce the concentration a metabolic enzyme process in the kidneys, resulting of cystine in the urine and deficiency in an excessive concentration of reduce its precipitating from this amino acid the urine and forming stone — Cystine precipitates out of the urine and forms stones in the kidneys, ureters, or bladder